Maryia Zhdanava, MA

Esketamine was associated with significantly larger improvements in work productivity loss and related costs compared to quetiapine, suggesting greater benefits from patient well-being and employer perspectives.

Acute suicidal ideation or behavior (SIB) that accompanies major depressive disorder (MDD) may produce a substantial economic burden. This study evaluated health care resource utilization and costs of commercially...